Clinical Trial Update: A Pivotal Study of HQP1351 in Patients With Chronic Myeloid Leukemia in Chronic Phase [Phase 2]

View source ↗

Summary

A Phase 2 pivotal study evaluating HQP1351 in patients with chronic myeloid leukemia in chronic phase has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• HQP1351

Snippet

Sponsor: Ascentage Pharma Group Inc. | Conditions: Chronic Myeloid Leukemia, Chronic Phase | Phase 2 | Status: COMPLETED